MDI-26478

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDI-26478
Drug Alias NameMDI-26478
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsSchizophreniaCognition DisordersBrain Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardiff University
China Registration ClassN/A

Develop Information

Active CompaniesCardiff University
Inactive CompaniesN/A
Active IndicationsSchizophreniaCognition DisordersBrain Diseases +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A